Naoya Hida
- Immunology top 10%
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 3
- Oncology top 10%
- Lung Cancer Research Studies 9
- Cancer Immunotherapy and Biomarkers 4
-
- Lung Cancer Treatments and Mutations 9
-
- vaccines and immunoinformatics approaches 5
-
- Asthma and respiratory diseases 4
Naoya Hida
34 papers receiving 396 citations
Peers
Comparison fields: 5 of 57
- Immunology 219
- Oncology 237
- Pulmonary and Respiratory Medicine 107
- Molecular Biology 152
- Hepatology 13
Countries citing papers authored by Naoya Hida
This map shows the geographic impact of Naoya Hida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoya Hida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoya Hida more than expected).
Fields of papers citing papers by Naoya Hida
This network shows the impact of papers produced by Naoya Hida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoya Hida. The network helps show where Naoya Hida may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoya Hida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 9 | |
| 4 | 2020 | 3 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 5 | |
| 9 | 2015 | 6 | |
| 10 | 2013 | 6 | |
| 11 | 2013 | 1 | |
| 12 | 2012 | 3 | |
| 13 | 2011 | 39 | |
| 14 | 2009 | 5 | |
| 15 | 2003 | 48 | |
| 16 | 2002 | 6 | |
| 17 | 2002 | 14 | |
| 18 | 2002 | 26 | |
| 19 | 2002 | 15 | |
| 20 | 2001 | 33 |
About Naoya Hida
Naoya Hida is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 34 papers that have together received 402 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (9 papers), Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers), T-cell and B-cell Immunology (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Asthma and respiratory diseases (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (219 citations), Oncology (237 citations) and Pulmonary and Respiratory Medicine (107 citations). Naoya Hida has collaborated with scholars based in Japan, United States and Finland. Frequent co-authors include Hiroaki Okamoto, Kyogo Itoh, Yoshiaki Maeda, Hideaki Yamana, Koshiro Watanabe, Katsuhiko Naoki, Takashi Mine, Kazuko Katagiri, Akira Yamada and Hiroshi Kunikane. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.